Galderma Investigational Site 5580

L'Hospitalet de Llobregat 08907

0 studies enrolling now · 2 studies all time

What they study most

Chronic Kidney Disease Associated Moderate to Severe Pruritus, Moderate-to-Severe Atopic Dermatitis

Studies at this site

• To Evaluate the Efficacy and Safety of Nemolizumab for 12 Weeks in Participants With Chronic Kidney Disease With Associated Moderate to Severe Pruritus — Completed
• Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis — Running, not enrolling